Calton & Associates’s Colgate-Palmolive CL Stock Holding History

Calton & Associates’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,643	Closed	-$126K	–	491
2017 Q4	$126K	Buy	+1,643	New	+$120K	0.03%	430

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Calton & Associates's CL Position: Q1 2018 in Review

Calton & Associates sold out of Colgate-Palmolive (CL) in Q1 2018, closing a stake of 1,643 shares — an estimated $126K sold.

Calton & Associates first reported a position in CL in Q4 2017 and held it in 1 quarter. The position peaked at $126K in Q4 2017. 1,439 funds tracked by Wall St. Rank hold CL as of Q1 2018.

Calton & Associates reported no remaining Colgate-Palmolive position as of Q1 2018 after selling out during the quarter.
Calton & Associates sold 1,643 Colgate-Palmolive shares in Q1 2018, an estimated $126K.
Calton & Associates first reported a position in Colgate-Palmolive in Q4 2017 and held it in 1 quarter.
Calton & Associates's Colgate-Palmolive position peaked at $126K in Q4 2017.
1,439 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2018.

Based on Calton & Associates's 13F filing for Q1 2018, filed 17 Apr 2018.